- Info
- Insider Trading
- Financials
- Holders: ENGN, ENGNW
enGene Therapeutics Inc. - *W EXP 10/31/202 (ENGNW)
CUSIP: 29286M113
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / *W EXP 10/31/202
- Total 13F shares
- 5,235,834
- Share change
- -37,149
- Total reported value
- $9,204,349
- Price per share
- $1.95
- Number of holders
- 14
- Value change
- -$41,253
- Number of sells
- 2
Quarterly Holders Quick Answers
What is CUSIP 29286M113?
CUSIP 29286M113 identifies ENGNW - enGene Therapeutics Inc. - *W EXP 10/31/202 in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 29286M113:
Top shareholders of ENGNW - enGene Therapeutics Inc. - *W EXP 10/31/202 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FCPM III SERVICES B.V. |
13F
|
Company |
—
mixed-class rows
|
11,556,099
mixed-class rows
|
$85,258,075 | — | 30 Jun 2024 | |
| Fonds de solidarite des travailleurs et des travailleuses du Quebec |
3/4/5
13D/G
|
10%+ Owner |
4.5%
from 13D/G
|
3,036,153
|
$45,542,295 | — | 18 Apr 2024 | |
| Lumira Capital Investment Management Inc. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,849,299
|
$38,492,990 | — | 20 Feb 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
4.9%
|
3,300,000
|
$31,119,000 | — | 30 Jun 2024 | |
| VR Adviser, LLC |
13F
|
Company |
4.2%
|
2,825,983
|
$26,649,020 | — | 30 Jun 2024 | |
| Blue Owl Capital Holdings LP |
13F
|
Company |
—
mixed-class rows
|
2,501,004
mixed-class rows
|
$23,710,170 | — | 30 Jun 2024 | |
| BVF INC/IL |
13F
|
Company |
—
mixed-class rows
|
3,196,439
mixed-class rows
|
$22,541,388 | — | 30 Jun 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
3.3%
|
2,250,000
|
$21,217,500 | — | 30 Jun 2024 | |
| Logos Global Management LP |
13F
|
Company |
1.8%
|
1,200,000
|
$11,316,000 | — | 30 Jun 2024 | |
| Omega Fund Management, LLC |
13F
|
Company |
—
mixed-class rows
|
1,397,859
mixed-class rows
|
$10,532,634 | — | 30 Jun 2024 | |
| Cormorant Asset Management, LP |
13F
|
Company |
1.5%
|
1,000,000
|
$9,430,000 | — | 30 Jun 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.5%
|
1,000,000
|
$9,040,000 | — | 30 Jun 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.2%
|
800,034
|
$7,544,321 | — | 30 Jun 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.2%
|
800,000
|
$7,544,000 | — | 30 Jun 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
1.2%
|
800,000
|
$7,544,000 | — | 30 Jun 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1.1%
|
764,645
|
$7,210,602 | — | 30 Jun 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
1.1%
|
727,900
|
$6,864,097 | — | 30 Jun 2024 | |
| Vivo Capital, LLC |
13F
|
Company |
1%
|
678,705
|
$6,400,188 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.91%
|
613,292
|
$5,783,343 | — | 30 Jun 2024 | |
| SR ONE CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.74%
|
500,000
|
$4,715,000 | — | 30 Jun 2024 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.63%
|
420,331
|
$3,963,721 | — | 30 Jun 2024 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.39%
|
263,841
|
$2,488,021 | — | 30 Jun 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.14%
|
97,000
|
$914,710 | — | 30 Jun 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.07%
|
43,900
|
$413,977 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
27,516
|
$259,475 | — | 30 Jun 2024 | |
| Saba Capital Management, L.P. |
13F
|
Company |
—
class O/S missing
|
192,334
|
$248,111 | — | 30 Jun 2024 | |
| Calamos Advisors LLC |
13F
|
Company |
—
class O/S missing
|
150,000
|
$208,500 | — | 30 Jun 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
—
class O/S missing
|
104,622
|
$145,425 | — | 30 Jun 2024 | |
| Verition Fund Management LLC |
13F
|
Company |
0.02%
|
14,843
|
$139,969 | — | 30 Jun 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.02%
|
12,524
|
$118,101 | — | 30 Jun 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
7,915
|
$75,000 | — | 30 Jun 2024 | |
| TENOR CAPITAL MANAGEMENT Co., L.P. |
13F
|
Company |
—
class O/S missing
|
55,243
|
$65,739 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
—
mixed-class rows
|
15,530
mixed-class rows
|
$46,249 | — | 30 Jun 2024 | |
| WHITEBOX ADVISORS LLC |
13F
|
Company |
—
class O/S missing
|
33,333
|
$39,666 | — | 30 Jun 2024 | |
| WOLVERINE ASSET MANAGEMENT LLC |
13F
|
Company |
—
class O/S missing
|
28,197
|
$33,554 | — | 30 Jun 2024 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
—
class O/S missing
|
23,570
|
$32,762 | — | 30 Jun 2024 | |
| CSS LLC/IL |
13F
|
Company |
—
class O/S missing
|
16,895
|
$20,105 | — | 30 Jun 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
972
|
$9,166 | — | 30 Jun 2024 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0%
|
600
|
$5,658 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
58
|
$547 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
—
class O/S missing
|
200
|
$238 | — | 30 Jun 2024 | |
| CLEAR STREET LLC |
13F
|
Company |
—
class O/S missing
|
200
|
$238 | — | 30 Jun 2024 | |
| Forbion Growth Sponsor FEAC I B.V. |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
5,502,338
mixed-class rows
|
— | — | 31 Oct 2023 | |
| Forbion Capital Fund III Cooperatief U.A. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,894,735
|
— | — | 31 Oct 2023 | |
| Jason David Hanson |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
512,826
|
— | — | 31 Oct 2023 | |
| Richard P. Bryce |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
153,000
|
— | — | 30 Nov 2023 | |
| James C. Sullivan |
3/4/5
|
Chief Scientific Officer |
—
class O/S missing
|
118,509
|
— | — | 31 Oct 2023 | |
| BVF PARTNERS L P/IL |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
104,257
|
— | — | 31 Oct 2023 |
Institutional Holders of enGene Therapeutics Inc. - *W EXP 10/31/202 (ENGNW) as of Q3 2024
As of 30 Sep 2024,
enGene Therapeutics Inc. - *W EXP 10/31/202 (ENGNW) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,235,834 shares.
The largest 10 holders included
FCPM III SERVICES B.V., BVF INC/IL, Blue Owl Capital Holdings LP, Omega Fund Management, LLC, Saba Capital Management, L.P., Calamos Advisors LLC, D. E. Shaw & Co., Inc., TENOR CAPITAL MANAGEMENT Co., L.P., WHITEBOX ADVISORS LLC, and STATE OF WISCONSIN INVESTMENT BOARD.
This page lists
14
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
14
Q3 2024 holders
14
Holder diff
0
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.